Orbimed Advisors LLC Oric Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 287,100 shares of ORIC stock, worth $2.16 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
287,100
Previous 522,968
45.1%
Holding current value
$2.16 Million
Previous $4.81 Million
17.96%
% of portfolio
0.09%
Previous 0.12%
Shares
9 transactions
Others Institutions Holding ORIC
# of Institutions
113Shares Held
59.3MCall Options Held
302KPut Options Held
7.7K-
Nextech Invest Ag5.29MShares$39.7 Million13.59% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$33 Million5.19% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$31.2 Million2.99% of portfolio
-
Viking Global Investors LP4MShares$30.1 Million0.21% of portfolio
-
Alkeon Capital Management LLC New York, NY3.7MShares$27.9 Million0.09% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $298M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...